The Senate Finance Committee has included in its health reform proposal so-called sunshine provisions that would promote transparency among drug and medical device makers that pay doctors for consultations and speeches. AdvaMed backed the sunshine initiative, and the Pharmaceutical Research and Manufacturers of America said any laws on payment disclosures should not imply that doctor-industry ties are inappropriate.

Full Story:

Related Summaries